Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Completed

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma

NCT00432458

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details
Completed

Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

NCT00925821

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Charité University Hospital - Virchow Klinikum Berlin, Germany
  • Dresden University Hospital Dresden, Germany
  • Erlangen University Hospital Erlangen, Germany
  • Freiburg University Hospital Freiburg im Breisgau, Germany
View Trial Details
Completed

Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)

NCT00372892

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +15 more
Locations
  • St. Paul's Hospital Vancouver, British Columbia, Canada
  • Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
  • McMaster Univerisity Hamilton, Ontario, Canada
  • Grand River Regional Cancer Centre Kitchener, Ontario, Canada
View Trial Details

Related conditions